These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 15689382)

  • 1. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
    Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
    Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis.
    Chang CP; Neilson JR; Bayle JH; Gestwicki JE; Kuo A; Stankunas K; Graef IA; Crabtree GR
    Cell; 2004 Sep; 118(5):649-63. PubMed ID: 15339668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers of cardiac endocardial cushion development.
    Gitler AD; Lu MM; Jiang YQ; Epstein JA; Gruber PJ
    Dev Dyn; 2003 Dec; 228(4):643-50. PubMed ID: 14648841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis.
    Hiemisch H; Schütz G; Kaestner KH
    EMBO J; 1997 Jul; 16(13):3995-4006. PubMed ID: 9233809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.
    Lange AW; Molkentin JD; Yutzey KE
    Dev Biol; 2004 Feb; 266(2):346-60. PubMed ID: 14738882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-box binding sites are required for activity of a cardiac GATA-4 enhancer.
    Heicklen-Klein A; Evans T
    Dev Biol; 2004 Mar; 267(2):490-504. PubMed ID: 15013808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sculpting heart valves with NFATc and VEGF.
    Lambrechts D; Carmeliet P
    Cell; 2004 Sep; 118(5):532-4. PubMed ID: 15339657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hoxa5 gene regulation: A gradient of binding activity to a brachial spinal cord element.
    Nowling T; Zhou W; Krieger KE; Larochelle C; Nguyen-Huu MC; Jeannotte L; Tuggle CK
    Dev Biol; 1999 Apr; 208(1):134-46. PubMed ID: 10075847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development.
    Dodou E; Verzi MP; Anderson JP; Xu SM; Black BL
    Development; 2004 Aug; 131(16):3931-42. PubMed ID: 15253934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation.
    Wu B; Wang Y; Lui W; Langworthy M; Tompkins KL; Hatzopoulos AK; Baldwin HS; Zhou B
    Circ Res; 2011 Jul; 109(2):183-92. PubMed ID: 21597012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Pax2 in the intermediate mesoderm is regulated by YY1.
    Patel SR; Dressler GR
    Dev Biol; 2004 Mar; 267(2):505-16. PubMed ID: 15013809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis.
    Kuisk IR; Li H; Tran D; Capetanaki Y
    Dev Biol; 1996 Feb; 174(1):1-13. PubMed ID: 8626009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.
    Thompson JR; Huang DY; Gudas LJ
    Cell Growth Differ; 1998 Dec; 9(12):969-81. PubMed ID: 9869297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
    Iwahori A; Fraidenraich D; Basilico C
    Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis.
    Witte DP; Aronow BJ; Dry JK; Harmony JA
    Dev Dyn; 1994 Nov; 201(3):290-6. PubMed ID: 7881131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 activates the acetylcholinesterase promoter in rat muscle.
    Cohen TV; Randall WR
    J Neurochem; 2004 Sep; 90(5):1059-67. PubMed ID: 15312161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.